13^th World Congress on Pharmacology and Toxicology November 14-15, 2018 | Mercure Albert Park | Melbourne, Australia

Conference Series llc Ltd is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. Currently we are bringing “13^th World Congress on Pharmacology and Toxicology” (Pharmacology Congress 2018) scheduled to be held during November 14-15, 2018 at Melbourne, Australia. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmacology and Toxicology.

Conference Series llc Ltd organizes a conference series of 3000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Pharmacology Congress 2018 focuses on the importance to understand drugs and how they can affect human physiology. It is with better understanding of Pharmacolo­gy one can know the right dosage and dosage forms of drugs. More research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat ac­cordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs. 

Why to attend???

Join your peers around the world focused on learning about Pharmacology, toxicology and related advances, which is your single best opportunity to reach the largest assemblage of participants from the Pharmacology and toxicology community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name and recognition at this 2-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Pharmacology are hallmarks of this conference. 

Target Audience:

• Students, Scientists, Researchers, and Faculty of Pharmaceutical Universities
• Medical Colleges, Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies
• Business Entrepreneurs, Training Institutes, Software developing companies
• Manufacturing Medical Devices Companies, CRO and Data Management Companies.

2018 Highlights:

• 300+ Participation (70 Industry: 30 Academia)
• 5+ Keynote Speakers
• 50+ Plenary Speakers
• 20+ Exhibitors
• 14 Innovative Educational Sessions
• 5+ Workshops
• B2B Meetings

Conference Series llc Ltd invites all the participants from all over the world to attend ‘13^th World Congress on Pharmacology and Toxicology’ during November 14-15, 2018, Melbourne, Australia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Pharmacology Congress 2018 is a global conclave to discuss and learn about the sessions viz., Pharmacology, Neuropharmacology and Psychopharmacology, Clinical pharmacology and receptor theory, Pharmacokinetics and Pharmacodynamics, Cardiovascular and Ethno pharmacology, Pharmacogenetics and Pharmacogenomics, Drug Screening and Discovery, Toxicology and Toxicology Studies, Food and Chemical Toxicology, Drug Toxicology, Environmental Toxicology, Human Toxicology, Toxicology Risk Assessment, Toxicology Consulting, Genetic Toxicology, Toxicology Global Market, Toxicological Pharmacovigilance, Toxicologist Reports Market analysis and Business Opportunity.  Conference Series llc Ltd organizes a conference series of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Track 1: Pharmacology

Pharmacology is the study of how substances interact with living organisms to produce a change in function. It deals with the research, discovery, and characterization of chemicals which show biological effects and the illumination of cellular and organism function in relation to these chemicals. If substances have medicinal properties, they are considered pharmaceuticals. The Pharmacology encompasses mechanisms of drug action, drug composition and properties, interactions, toxicology, therapies, medical applications, and antipathogenic capabilities.

Related Conferences: Pharmacology Symposium | Pharmacology Conferences | Pharmacology Meetings | Pharmacology Congress

16^th Global Summit on Toxicology and Applied Pharmacology during October 15-16, 2018 at Las Vegas, USA; 15^th Euro-Global Summit on Toxicology and Applied Pharmacology during July 02-04, 2018 at Berlin, Germany; 17^th Global Toxicology and Risk Assessment Conference during October 22-24, 2018 at Athens, Greece; 17^th International Conference on Environmental Toxicology and Ecological Risk Assessment during September 24-25, 2018 at Chicago, USA; 10th World Congress on Pharmacology during July 30-August 01, 2018 at Barcelona, Spain; 4th International Conference and Expo on Drug Discovery, Drug Designing & Development during September 06-07, 2018 at London, UK

18th World Congress of Basic and Clinical Pharmacology Congress during July 1-6, 2018 at Kyoto, Japan; 20th International Conference on Pharmacology Congress and Toxicology Conference, during May 10 - 11, 2018 at Amsterdam, The Netherlands; 20th International Conference on Pharmacy and Pharmacology Congress during February 15 - 16, 2018 at London, United Kingdom; APNA 16th Annual Clinical Psychopharmacology Conference Institute (CPI) - American Psychiatric Conference Nurses Association during June 07-10, 2018; APNA 16th Annual Clinical Psychopharmacology Conference Institute (CPI) - American Psychiatric Nurses Association during  June 07-10, 2018 at Baltimore, USA

Related Societies: Academy of Toxicological Sciences; American Board of Toxicology; Society of Toxicology of Canada; International Union of Toxicology; American College of Medical Toxicology; Argentine Toxicological Association; The Australian society of clinical and experimental pharmacologists and toxicologists (ASCEPT)

Track 2: Toxicology

Toxicology is the scientific study of adverse effects that occur in living organisms due to chemicals. It involves observing and reporting symptoms, mechanisms, detection and treatments of toxic substances, in particular relation to the poisoning of humans. It includes environmental agents and chemical compounds found in nature, as well as pharmaceutical compounds that are synthesized for medical use by humans. These substances may produce toxic effects in living organisms including disturbance in growth patterns, discomfort, disease and death. LD50 is a common term used in toxicology, which refers to the dose of a substance that displays toxicity in that it kills 50% of a test population. In scientific research, rats or other surrogates are usually used to determine toxicity and the data are extrapolated to use by humans.

Related Conferences: Toxicology Symposium | Toxicology Conferences | Toxicology Workshop | Toxicology Congress

9th Global Experts Meeting on Neuropharmacology during November 15-16, 2018 at Frankfurt, Germany; 11^th International Conference and Exhibition on Pharmacovigilance and Drug Safety Conference during June 21-22, 2018 at London, UK; 12^th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry during February 26-27, 2018 at London, UK; 11^th European Biosimilars Conference during April 26-27, 2018 at Rome, Italy; 11^th European Biosimilars Congress during April 26-27, 2018 at Rome, Italy

DIA 2018 Annual Meeting - Drug Information Association, during June 24-28, 2018 at Boston, USA; ACCP Annual Meeting - American College Of Clinical Pharmacology Conference at North Bethesda, MD during November 23-25, 2018; SOCRA's 27th Annual Conference - Society of Clinical Research Associates during November 28-30, 2018 at New Orleans, LA; 2018 SPS Joint Annual Meeting - Safety Pharmacology Conference Society at Washington, DC during   September 29-October 03, 2018; AAPS Annual Meeting & Exposition 2018 - American Association of Pharmaceutical Scientists at Washington, DC  during November 04-08, 2018

Related Societies: Austrian Society of Toxicology; Colombia Society of Toxicology; European Federation of Neurological Societies; National Institute of Neurological Disorders and Stroke; Australian Neuroscience Society; The American Clinical Neurophysiology Society; European Association for Clinical Pharmacology and Therapeutics (EACPT)

Track 3: Clinical Pharmacology & Receptor Therapy

Clinical Pharmacology has been practiced for centuries through observing the effects of herbal remedies and early drugs on humans. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamics parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance. Since long scientific advances allowed scientists to come together with the study of physiological effects with biological effects, Receptor theory for drug effects and its discovery with clinical pharmacology has stretched out to be a multidisciplinary field and has contributed to the findings of drug interaction, therapeutic effectiveness and safety. Drug interactions and pharmacological compatibilities include the study of pharmacokinetics that includes the absorption, distribution, metabolism, and elimination of drugs. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamics parameters become especially important because of the association between drug application, microorganism abolition, and resistance.

Related Conferences: Clinical Pharmacology Symposium | Clinical Pharmacology Conferences | Clinical Pharmacology Workshop | Clinical Pharmacology Congress

18th Global Summit on Environmental Toxicology and Pharmacology during September 17-18, 2018 at Singapore; 10th World Congress on Pharmacology during July 30-August 01, 2018 at Barcelona, Spain; 6th international Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products during September 17-18, 2018 at Shanghai, China; 15th Asia-Pacific Pharma Congress during July 18-20, 2018 at Melbourne, Australia; 2nd International Conference and Exhibition on Pharmaceutical Development and Technology during May 11-12, 2018 at Tokyo, Japan; 4th International Conference and Exhibition on Natural Products, Medicinal Plants & Marine Drugs during June 11-12, 2018 at Rome, Italy

Antibody Drug Conjugates conference during January 08-11, 2018 at San Diego, USA; Global Pharmaceutical Conference And Medical Meetings Summit during February 01-03, 2018 at Philadelphia, USA; Monitoring Safety in Clinical Trials Conference and Drug Development Conference during February 07-08, 2018 at UK; Outsourcing in Clinical Trials Conference: Medical Devices Europe during February 06-09, 2018 at Munich, Germany; Pharma Market Research Conference  at Newark,  USA; Annual Psychopharmacology Update Conference at Las Vegas, USA

Related Societies: British Pharmacological Society (BPS); American society for Clinical Pharmacology (ASCPT); Chinese Pharmacological Society; International Society of Neuropathology(ISN); International Society of Psychoneuroendocrinology (ISPNE); Federation of European Neuroscience Societies (FENS); American Society for Clinical Pharmacology and Therapeutics

Track 4: Psychopharmacology & Neuropharmacology

Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviours and how molecular events are manifest in a measurable behavioural form. Neuropharmacology is the study of the effects of medication on central and peripheral nervous system performance. Neurogenesis and repair deal with other aspects on the indications for medications prescribed to address psychiatric and behavioural problems, that are associated with, including antipsychotic, anxiolytic and anticonvulsant medications, acquired brain injury and Neurocognitive effects associated with therapeutic drugs also include mood stabilizers and treatments prescribed for disorders of attention. The treatments may cause side effects such as induction of the metabolic syndrome, type-2 diabetes related to the medications prescribed for management of psychiatric and behavioural disorders and disturbances. Ethno psychopharmacology also deals with the biotransformation and metabolism of medications, as well as specific differential actions: i.e., CYP450 enzymatic inhibition and induction of metabolism of psychopharmacological and herbaceutical substrates. Neuropharmacology is the study of drugs and their targets that influence the functions of the nervous system (brain, spinal cord, and peripheral nerves) in health and disease.

Related Conferences: Psychopharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Psychopharmacology Congress

11th International Conference and Exhibition on Pharmacovigilance & Drug Safety during June 21-22, 2018 at London, UK; 8th International Conference on Environmental Chemistry and Engineering during September 20-22, 2018 at Berlin, Germany; 12^th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry during February 26-27 2018, at London, UK; 4th World Congress and Exhibition on Antibiotics and Antibiotic Resistance during June 14-15, 2018 at Barcelona, Spain; 10th Annual European Pharma Congress during May 07-09, 2018 at Frankfurt, Germany; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology during April 09-11, 2018 at Amsterdam, Netherlands

Biomarkers Congress at Manchester, UK; Ubiquitin Research and Drug Discovery Conference at San Diego, USA;  BioPharma Asia Convention during March 01-02, 2018 at Singapore; Future of Genomic Medicine conference during March 01-02, 2018 at San Diego, USA; Clinical Audit Summit: Clinical Audit for Improvement on March 05, 2018 at London, UK; DIA 2018 Annual Meeting - Drug Information Association, during June 24-28, 2018 at Boston, USA

Related Societies: Academy of Toxicological Sciences; American Board of Toxicology; Society of Toxicology of Canada; International Union of Toxicology; American College of Medical Toxicology; Argentine Toxicological Association; The Australian society of clinical and experimental pharmacologists and toxicologists (ASCEPT)

Track 5: Pharmacokinetics & Pharmacodynamics

Pharmacodynamics is the effect that drugs have on the body; while pharmacokinetics is the study of the way in which drugs move through the body during absorption, distribution, metabolism and excretion. Pharmacokinetics influences decisions over the route of administration. For drugs to produce their effects they must interact with the body. This can happen in many ways and depends on the properties of the drug. Pharmacokinetics influences decisions over the route of administration. The processes that occur after drug administration can be broken down into four distinct areas (known as ADME):

A  Absorption of the drug

D Distribution of the drug molecules

M Metabolism of the parent drug

E Excretion or elimination of the drug and its metabolites

Related Conferences: Pharmacology Symposium | Pharmacology Conferences | Pharmacology Workshop | Pharmacology Congress | Pharmacology Summit

16^th Global Summit on Toxicology and Applied Pharmacology during October 15-16, 2018 at Las Vegas, USA; 15^th Euro-Global Summit on Toxicology and Applied Pharmacology during July 02-04, 2018 at Berlin, Germany; 17^th Global Toxicology and Risk Assessment Conference during October 22-24, 2018 at Athens, Greece; 17^th International Conference on Environmental Toxicology and Ecological Risk Assessment during September 24-25, 2018 at Chicago, USA; 10th World Congress on Pharmacology during July 30-August 01, 2018 at Barcelona, Spain; 4th International Conference and Expo on Drug Discovery, Drug Designing & Development during September 06-07, 2018 at London, UK

18th World Congress of Basic and Clinical Pharmacology Congress during July 1-6, 2018 at Kyoto, Japan; 20th International Conference on Pharmacology Congress and Toxicology Conference, during May 10 - 11, 2018 at Amsterdam, The Netherlands; 20th International Conference on Pharmacy and Pharmacology Congress during February 15 - 16, 2018 at London, United Kingdom; APNA 16th Annual Clinical Psychopharmacology Conference Institute (CPI) - American Psychiatric Conference Nurses Association during June 07-10, 2018; APNA 16th Annual Clinical Psychopharmacology Conference Institute (CPI) - American Psychiatric Nurses Association during  June 07-10, 2018 at Baltimore, USA

Related Societies: Austrian Society of Toxicology; Colombia Society of Toxicology; European Federation of Neurological Societies; National Institute of Neurological Disorders and Stroke; Australian Neuroscience Society; The American Clinical Neurophysiology Society; European Association for Clinical Pharmacology and Therapeutics (EACPT)

Track 6: Cardiovascular Pharmacology

Cardio pharmacodynamics of digitalis is most frequently used to increase the adequacy of the circulation in patients with CCF and to slow the ventricular rate in patients with atrial fibrillation or flutter NB. The main action of digitalis is its ability to increase myocardial contractility and its positive isotropic action resulting in increased cardiac output, decreased heart size, decreased venous pressure, decreased circulating blood volume, diuresis and relief of edema as digitalis frequently causes a dramatic reduction in the ventricular rate. It was originally believed that this was the main effect subsequently shown to be beneficial irrespective of the HR, its predominant effects being on contractility in addition to the cardiac effects, digitalis has a direct action on vascular smooth muscle, neural tissue. The later being responsible for indirect cardiac actions of the drug which frequently result in reflex autonomic & hormonal changes which affect the CVS.  The circulatory system is busy providing oxygen and nourishment to every cell of the body, let's not forget that the heart, which works hardest of all, needs nourishment.

Related Conferences: Pharmacology Symposium | Pharmacology Conferences | Pharmacology Workshop | Pharmacology Congress | Pharmacology Summit

9th Global Experts Meeting on Neuropharmacology during November 15-16, 2018 at Frankfurt, Germany; 11^th International Conference and Exhibition on Pharmacovigilance and Drug Safety Conference during June 21-22, 2018 at London, UK; 12^th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry during February 26-27, 2018 at London, UK; 11^th European Biosimilars Conference during April 26-27, 2018 at Rome, Italy; 11^th European Biosimilars Congress during April 26-27, 2018 at Rome, Italy

DIA 2018 Annual Meeting - Drug Information Association, during June 24-28, 2018 at Boston, USA; ACCP Annual Meeting - American College Of Clinical Pharmacology Conference at North Bethesda, MD during November 23-25, 2018; SOCRA's 27th Annual Conference - Society of Clinical Research Associates during November 28-30, 2018 at New Orleans, LA; 2018 SPS Joint Annual Meeting - Safety Pharmacology Conference Society at Washington, DC during   September 29-October 03, 2018; AAPS Annual Meeting & Exposition 2018 - American Association of Pharmaceutical Scientists at Washington, DC  during November 04-08, 2018

Related Societies: British Pharmacological Society (BPS); American society for Clinical Pharmacology (ASCPT); Chinese Pharmacological Society; International Society of Neuropathology(ISN); International Society of Psychoneuroendocrinology (ISPNE); Federation of European Neuroscience Societies (FENS); American Society for Clinical Pharmacology and Therapeutics

Track 7: Pharmacogenetics & Pharmacogenomics

Recent advances in DNA repair are DNA interstrand cross-links (ICLs) are lesions caused by a variety of endogenous metabolites, ecological exposures, and cancer chemotherapeutic agents that have two reactive groups. The general feature of these diverse lesions is that two nucleotides on opposite strands are joined covalently. Mutagenicity and carcinogenicity are clearly correlated. The somatic mutation theory of cancer holds that these agents cause cancer by causing the mutation of somatic cells. A unique feature of inter-strand cross-links repair is that both strands of DNA must be incised to completely remove the lesion. Drug dosing guidelines accomplished in sequential steps to prevent creating multiple double-strand breaks. Understanding the specificity of mutagens in bacteria has led to the direct implication of certain environmental mutagens in the cause of human cancers.

Related Conferences: Pharmacology Symposium | Pharmacology Conferences | Pharmacology Workshop | Pharmacology Congress | Pharmacology Summit

18th Global Summit on Environmental Toxicology and Pharmacology during September 17-18, 2018 at Singapore; 10th World Congress on Pharmacology during July 30-August 01, 2018 at Barcelona, Spain; 6th international Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products during September 17-18, 2018 at Shanghai, China; 15th Asia-Pacific Pharma Congress during July 18-20, 2018 at Melbourne, Australia; 2nd International Conference and Exhibition on Pharmaceutical Development and Technology during May 11-12, 2018 at Tokyo, Japan; 4th International Conference and Exhibition on Natural Products, Medicinal Plants & Marine Drugs during June 11-12, 2018 at Rome, Italy

Antibody Drug Conjugates conference during January 08-11, 2018 at San Diego, USA; Global Pharmaceutical Conference And Medical Meetings Summit during February 01-03, 2018 at Philadelphia, USA; Monitoring Safety in Clinical Trials Conference and Drug Development Conference during February 07-08, 2018 at UK; Outsourcing in Clinical Trials Conference: Medical Devices Europe during February 06-09, 2018 at Munich, Germany; Pharma Market Research Conference  at Newark,  USA; Annual Psychopharmacology Update Conference at Las Vegas, USA

Related Societies: Academy of Toxicological Sciences; American Board of Toxicology; Society of Toxicology of Canada; International Union of Toxicology; American College of Medical Toxicology; Argentine Toxicological Association; The Australian society of clinical and experimental pharmacologists and toxicologists (ASCEPT)

Track 8: Drug Discovery and Drug Screening

Reverse pharmacology and forward pharmacology are two approaches to drug discovery. Target based drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Screening of chemical libraries and its pharmacology, methods to determine biological targeting by systematically perturbing and interrogating biological pathways with synthetically novel chemical tools, preclinical validation of target biology is beginning to illuminate a more cost effective and efficient paradigm for the development of novel drugs modulating novel targets.

Related Conferences: Pharmacology Symposium | Pharmacology Conferences | Pharmacology Workshop | Pharmacology Congress | Pharmacology Summit

11th International Conference and Exhibition on Pharmacovigilance & Drug Safety during June 21-22, 2018 at London, UK; 8th International Conference on Environmental Chemistry and Engineering during September 20-22, 2018 at Berlin, Germany; 12^th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry during February 26-27 2018, at London, UK; 4th World Congress and Exhibition on Antibiotics and Antibiotic Resistance during June 14-15, 2018 at Barcelona, Spain; 10th Annual European Pharma Congress during May 07-09, 2018 at Frankfurt, Germany; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology during April 09-11, 2018 at Amsterdam, Netherlands

Biomarkers Congress at Manchester, UK; Ubiquitin Research and Drug Discovery Conference at San Diego, USA;  BioPharma Asia Convention during March 01-02, 2018 at Singapore; Future of Genomic Medicine conference during March 01-02, 2018 at San Diego, USA; Clinical Audit Summit: Clinical Audit for Improvement on March 05, 2018 at London, UK; DIA 2018 Annual Meeting - Drug Information Association, during June 24-28, 2018 at Boston, USA

Related Societies: Austrian Society of Toxicology; Colombia Society of Toxicology; European Federation of Neurological Societies; National Institute of Neurological Disorders and Stroke; Australian Neuroscience Society; The American Clinical Neurophysiology Society; European Association for Clinical Pharmacology and Therapeutics (EACPT)

Track 9: Environmental Toxicology & Human Toxicology

Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man. Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxic kinetics (including toxic kinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals. Human toxicology studies address the mechanisms/modes of toxicity that deals with the safety evaluation of novel chemical, biotechnologically-derived products, and nanomaterials for human health assessment including statistical and mechanism-based approaches. This also includes novel methods or approaches to research on animal and human tissues (medical and veterinary patients) investigating functional, biochemical and structural disorder.

Related Conferences: Pharmacology Symposium | Pharmacology Conferences | Pharmacology Workshop | Pharmacology Congress | Pharmacology Summit

16^th Global Summit on Toxicology and Applied Pharmacology during October 15-16, 2018 at Las Vegas, USA; 15^th Euro-Global Summit on Toxicology and Applied Pharmacology during July 02-04, 2018 at Berlin, Germany; 17^th Global Toxicology and Risk Assessment Conference during October 22-24, 2018 at Athens, Greece; 17^th International Conference on Environmental Toxicology and Ecological Risk Assessment during September 24-25, 2018 at Chicago, USA; 10th World Congress on Pharmacology during July 30-August 01, 2018 at Barcelona, Spain; 4th International Conference and Expo on Drug Discovery, Drug Designing & Development during September 06-07, 2018 at London, UK

18th World Congress of Basic and Clinical Pharmacology Congress during July 1-6, 2018 at Kyoto, Japan; 20th International Conference on Pharmacology Congress and Toxicology Conference, during May 10 - 11, 2018 at Amsterdam, The Netherlands; 20th International Conference on Pharmacy and Pharmacology Congress during February 15 - 16, 2018 at London, United Kingdom; APNA 16th Annual Clinical Psychopharmacology Conference Institute (CPI) - American Psychiatric Conference Nurses Association during June 07-10, 2018; APNA 16th Annual Clinical Psychopharmacology Conference Institute (CPI) - American Psychiatric Nurses Association during  June 07-10, 2018 at Baltimore, USA

Related Societies: British Pharmacological Society (BPS); American society for Clinical Pharmacology (ASCPT); Chinese Pharmacological Society; International Society of Neuropathology(ISN); International Society of Psychoneuroendocrinology (ISPNE); Federation of European Neuroscience Societies (FENS); American Society for Clinical Pharmacology and Therapeutics

Track 10: Food and Chemical Toxicology

Food and Chemical Toxicology (FCT), an internationally renowned journal, that publishes original research articles and reviews on toxic effects, in animals and humans, of natural or synthetic chemicals occurring in the human environment with particular emphasis on food, drugs and chemicals, including agricultural and industrial safety, and consumer product safety. Areas such as safety evaluation of novel foods and ingredients, biotechnologically-derived products and nanomaterials are included in the scope of the journal. FCT also encourages submission of papers on inter-relationships between nutrition and toxicology and on in vitro techniques. Furthermore new areas such as safety evaluation of novel foods and biotechnologically derived products and inter-relationships between nutrition and toxicology are welcomed. The studies may address the physiological, biochemical or pathological changes induced by specific substances, techniques for assessing potential toxicity, including molecular biology or the mechanisms underlying toxic phenomena.

Related Conferences: Toxicology Symposium |  Toxicology Conferences |  Toxicology Workshop |  Toxicology Congress |  Toxicology Summit

9th Global Experts Meeting on Neuropharmacology during November 15-16, 2018 at Frankfurt, Germany; 11^th International Conference and Exhibition on Pharmacovigilance and Drug Safety Conference during June 21-22, 2018 at London, UK; 12^th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry during February 26-27, 2018 at London, UK; 11^th European Biosimilars Conference during April 26-27, 2018 at Rome, Italy; 11^th European Biosimilars Congress during April 26-27, 2018 at Rome, Italy

DIA 2018 Annual Meeting - Drug Information Association, during June 24-28, 2018 at Boston, USA; ACCP Annual Meeting - American College Of Clinical Pharmacology Conference at North Bethesda, MD during November 23-25, 2018; SOCRA's 27th Annual Conference - Society of Clinical Research Associates during November 28-30, 2018 at New Orleans, LA; 2018 SPS Joint Annual Meeting - Safety Pharmacology Conference Society at Washington, DC during   September 29-October 03, 2018; AAPS Annual Meeting & Exposition 2018 - American Association of Pharmaceutical Scientists at Washington, DC  during November 04-08, 2018

Related Societies: Academy of Toxicological Sciences; American Board of Toxicology; Society of Toxicology of Canada; International Union of Toxicology; American College of Medical Toxicology; Argentine Toxicological Association; The Australian society of clinical and experimental pharmacologists and toxicologists (ASCEPT)

Track 11: Genotoxicity

Genetic toxicology helps discern the possibility of heritable mutations, developmental defects, cancer initiation, aging and other long-term adverse genetic effects. Genotoxicity describes the assets of chemical sellers that damage the genetic records inside cellular causing mutations, which may lead to most cancers. At the same time, genotoxicity is often stressed with mutagenicity; all mutagens are genotoxic, while no longer all genotoxic materials are mutagenic. The alteration could have direct or indirect consequences at the DNA: the induction of mutations, mistimed occasion activation, and direct DNA damage leading to mutations.

Related Conferences: Toxicology Symposium |  Toxicology Conferences |  Toxicology Workshop |  Toxicology Congress |  Toxicology Summit

18th Global Summit on Environmental Toxicology and Pharmacology during September 17-18, 2018 at Singapore; 10th World Congress on Pharmacology during July 30-August 01, 2018 at Barcelona, Spain; 6th international Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products during September 17-18, 2018 at Shanghai, China; 15th Asia-Pacific Pharma Congress during July 18-20, 2018 at Melbourne, Australia; 2nd International Conference and Exhibition on Pharmaceutical Development and Technology during May 11-12, 2018 at Tokyo, Japan; 4th International Conference and Exhibition on Natural Products, Medicinal Plants & Marine Drugs during June 11-12, 2018 at Rome, Italy

Antibody Drug Conjugates conference during January 08-11, 2018 at San Diego, USA; Global Pharmaceutical Conference And Medical Meetings Summit during February 01-03, 2018 at Philadelphia, USA; Monitoring Safety in Clinical Trials Conference and Drug Development Conference during February 07-08, 2018 at UK; Outsourcing in Clinical Trials Conference: Medical Devices Europe during February 06-09, 2018 at Munich, Germany; Pharma Market Research Conference  at Newark,  USA; Annual Psychopharmacology Update Conference at Las Vegas, USA

Related Societies: Austrian Society of Toxicology; Colombia Society of Toxicology; European Federation of Neurological Societies; National Institute of Neurological Disorders and Stroke; Australian Neuroscience Society; The American Clinical Neurophysiology Society; European Association for Clinical Pharmacology and Therapeutics (EACPT)

Track 12: Ethnopharmacology

Ethnopharmacology is a study or comparison of the traditional medicine practiced by various ethnic groups and especially by indigenous peoples. The word ethnomedicine is sometimes used as a synonym for traditional medicine. Ethnomedical research is interdisciplinary; in its study of traditional medicines, it applies the methods of ethnobotany and medical anthropology. Often, the medicine traditions it studies are preserved only by oral tradition.

Scientific ethnomedical studies constitute either anthropological research or drug discovery research. Anthropological studies examine the cultural perception and context of a traditional medicine. The purpose of drug discovery research is to identify and develop a marketable pharmaceutical product. Various streams of ethnopharmacology include clinical ethnopharmacy and ethnopharmaceutics.

Related Conferences: Pharmacology Symposium | Pharmacology Conferences | Pharmacology Workshop | Pharmacology Congress | Pharmacology Summit

11th International Conference and Exhibition on Pharmacovigilance & Drug Safety during June 21-22, 2018 at London, UK; 8th International Conference on Environmental Chemistry and Engineering during September 20-22, 2018 at Berlin, Germany; 12^th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry during February 26-27 2018, at London, UK; 4th World Congress and Exhibition on Antibiotics and Antibiotic Resistance during June 14-15, 2018 at Barcelona, Spain; 10th Annual European Pharma Congress during May 07-09, 2018 at Frankfurt, Germany; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology during April 09-11, 2018 at Amsterdam, Netherlands

Biomarkers Congress at Manchester, UK; Ubiquitin Research and Drug Discovery Conference at San Diego, USA;  BioPharma Asia Convention during March 01-02, 2018 at Singapore; Future of Genomic Medicine conference during March 01-02, 2018 at San Diego, USA; Clinical Audit Summit: Clinical Audit for Improvement on March 05, 2018 at London, UK; DIA 2018 Annual Meeting - Drug Information Association, during June 24-28, 2018 at Boston, USA

Related Societies: British Pharmacological Society (BPS); American society for Clinical Pharmacology (ASCPT); Chinese Pharmacological Society; International Society of Neuropathology(ISN); International Society of Psychoneuroendocrinology (ISPNE); Federation of European Neuroscience Societies (FENS); American Society for Clinical Pharmacology and Therapeutics

Importance & Scope:

‘Pharmacology Congress 2018’ is a perfect platform to present and discuss current perspectives in drug research and development. Pharmacology is the study of interaction of chemical with living systems. It is a medical science that forms a backbone of the medical profession. So, it’s important to describe the pharmacological basis of therapeutics in order to maximize the benefits and minimize the risks of drugs to recipients. It is an integrative rather than an autonomous science, drawing on the techniques and knowledge of many allied scientific disciplines. Hence it will be a platform for researchers, scientists, professional involved with drug development.

Market Analysis of Pharmacology and Related Research

Healthcare CRO Market to Reach $45.2 Billion By 2022

Global Healthcare CRO industry is expected to reach USD 45.2 billion by 2022, according to a new report by Grand View Research Inc. With the increasing number of patents expiring, increasing number of partnerships to identify biologics and new compounds and growing R&D costs, drug maker and sponsor companies are under pressure to replace the revenue loss specifically due to generics, which has further made drug development more expensive and complex.

Moreover, owing to the increasing incidence rates of chronic diseases such as cancer, Alzheimer’s and other infectious diseases in children, government funding has increased, which have led to increasing R&D activities.

Global pharmacovigilance market, by clinical trials, 2012 – 2020 (USD Million)

Increasing incidence rates of ADR (adverse drug reaction) clubbed with the introduction of stringent government policies pertaining to drug safety regulations are some key factors expected to drive the pharmacovigilance market. Pharmacovigilance is referred as an act of collection, detection, reporting and monitoring of adverse drug reaction. The global pharmacovigilance market was valued at USD 2,408.0 million in 2013 and is expected to grow at a CAGR of 12.6% during the forecast period. ADR represents a substantial burden on healthcare systems and is one of the prominent reasons of morbidity in developed countries. Approximately 5% of total hospitalizations in a year are due to ADR which makes reporting and preventing of the same a notable growth fuelling factor for this market. Growing prevalence of chronic disorders coupled with rising geriatric population base has heightened the need for new drug development. With an upsurge in the drug production, regulatory authorities such as the U.S. FDA and EMEA (European Medicines Agency) have intensified drug safety regulations prior and post commercialization. Growing complexity of drug safety regulations is thus, expected to boost market growth during the forecast period. Additionally, there is an additional pressure from the regulators for electronic submission especially in European countries which would further accentuate the demand for this market in this region.

Worldwide Total Pharmaceutical R & D spend in 2006 - 2020

We are unaware of exact validated statistics which accurately estimate the volume of clinical trial logistics services. Thus, such volume is traditionally calculated as a percentage of the total clinical trials expenses. According to the forecast made by Evaluate Pharma, in the next 5 years the clinical trials market will show a stable low growth of 2-2.5% per year, while being accompanied by a significant paradigm shift in the operational structure of cold-chain logistics and clinical trial supply, the costs of which (including manufacturing), by various estimates, may reach up to 20% of the total R&D costs. 

According to the same report, this trend of disproportionate growth will come from an increase in clinical trials of prescription medications where logistical expenses are traditionally higher than those of trials of generic products. 
Also noteworthy is the prediction that by 2020 R&D projects of top-20 pharmaceutical companies will account for more than 60% of total clinical trial expenses.

Cardiovascular Surgical Devices: Technologies and Global Markets

The global market for cardiovascular surgical devices was valued at $29.7 billion in 2012. This market is expected to reach nearly $31.7 billion in 2013 and nearly $47.2 billion by 2018, a compound annual growth rate (CAGR) of 8.3% for the period of 2013 to 2018.

BCC analyses the industry on a worldwide basis from market, product and technology perspectives. Regulations and reimbursement issues and patents issued from 2010 through mid-2013 are also examined to identify patient safety, regulatory review and insurance coverage issues for stakeholders and potential stakeholders in this industry.

Blood-Brain Barrier Technologies and Global Markets

The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

Pharmacology Research and Development Forecast

Pharmaceutical industry is experiencing a rather drastic redistribution of R&D activities to new geographic regions. According to the Biopharma Cold Chain 2012 Sourcebook, in 2016 up to 65% of growth in clinical research will come from studies conducted in emerging market counties: Asia Pacific, Eastern Europe and South America. While the majority of clinical trials are initiated with the end goal of NDA approval in the US and in Western Europe, the vast majority of potential study subjects live outside of these regions. Thus, there is a clearly identifiable need to develop first-rate, cost-effective clinical trial infrastructure capabilities in Asia-Pacific region, Latin America, Eastern Europe and potentially in North and South Africa. BRICS countries have demonstrated willingness to make their patients more available to international clinical trials. For instance, Russia and China have recently taken steps towards simplifying the launch of clinical trials.

 Major Societies of Pharmacology around the globe

• American Academy of Veterinary Pharmacology and Therapeutics
• American Board of Clinical Pharmacology
• Danish Society for Clinical Pharmacology
• American College of Clinical Pharmacology       
• American Society for Pharmacology and Experimental Therapeutics     
• Belgian Society of Fundamental and Clinical Physiology and Pharmacology
• Canadian Society of Pharmacology and Therapeutics
• Chinese Pharmacological Society
• Egyptian Society of Pharmacology and Experimental Therapeutics
• European Behavioural Pharmacology Society
• German Society for Clinical Pharmacology and Therapy
• Indonesia Veterinary Pharmacy and Pharmacology Association
• Japanese Society of Clinical Pharmacology and Therapeutics
• Serbian Medical Association, Section of Clinical Pharmacology

Best Global Universities for Pharmacology and Toxicology

• Harvard University
• United States Cambridge, MA
• University of North Carolina
• United States Chapel Hill
• University of California--San Francisco
• University of Washington United States Seattle
• University of California--San Diego
• United States La Jolla
• University of Copenhagen
• University College London
• Karolinska Institute
• Utrecht University
• University of Michigan--Ann Arbor
• University of Toronto
• Canada Toronto, Ontario
• Duke University
• United States Durham
• Johns Hopkins University
• United States Baltimore